United States was Glaukos’s largest region in fiscal 2025, bringing in $298.59M of $430.99M (69%).
| Geography | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| United States | $144.66M | $151.48M | $199.57M | $298.59M | ||||||
| International | $69.58M | $95.32M | $113.39M | $132.40M | ||||||
| Total | $214.24M | $246.79M | $312.96M | $430.99M |
Glaukos brought in $430.99M from its two regions in fiscal 2025, the year ended December 31, 2025. That was up 37.7% from $312.96M in fiscal 2024. United States was the largest at $298.59M (69.3%), ahead of International at $132.40M (30.7%).
Compared with fiscal 2024, United States grew 49.6% to $298.59M and International grew 16.8% to $132.40M. From fiscal 2022 to 2025, combined revenue from these regions grew from $214.24M to $430.99M, a compound annual growth rate of 26.2%. United States' share of the total rose from 67.5% to 69.3%.
Glaucoma was Glaukos’s largest product and service line in fiscal 2025, bringing in $298.59M of $384.96M (78%).
| Product and Service | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Glaucoma | $144.66M | $151.48M | $199.57M | $298.59M | |||||
| Corneal Health | $58.58M | $77.67M | $80.21M | $86.37M | |||||
| Total | $203.24M | $229.15M | $279.78M | $384.96M |
Glaukos brought in $384.96M from its two product and service lines in fiscal 2025, the year ended December 31, 2025. That is less than the $430.99M it reports by geography, so these lines do not cover all of its revenue. Glaucoma was the largest at $298.59M (77.6%), ahead of Corneal Health at $86.37M (22.4%).
Compared with fiscal 2024, Glaucoma grew 49.6% to $298.59M and Corneal Health grew 7.7% to $86.37M.
Glaukos (GKOS) reports its revenue by geography and by product and service. In fiscal 2025, United States was its largest region, bringing in $298.59M (69.3% of the total), followed by International at $132.40M (30.7%).
United States was Glaukos' largest region in fiscal 2025, bringing in $298.59M, or 69.3% of the $430.99M total across its two regions.
Glaucoma was Glaukos' largest product and service line in fiscal 2025, bringing in $298.59M, or 77.6% of the $384.96M total across its two product and service lines.
United States grew faster than International in fiscal 2025, up 49.6% from $199.57M to $298.59M. International grew 16.8% to $132.40M.
Every figure comes from Glaukos' annual financial filings, as reported. Each line keeps the name Glaukos gives it, and years follow its fiscal calendar.
Glaukos' revenue by geography goes back to fiscal 2016, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.